Ganz J C, Reda W A, Abdelkarim K
Gamma Knife Center Cairo, Nasser Institute, Shobra, Cairo, Egypt.
Acta Neurochir (Wien). 2009 Jan;151(1):1-8. doi: 10.1007/s00701-008-0166-4. Epub 2008 Dec 19.
Gamma Knife treatment is traditionally limited to tumours with a diameter not exceeding 3-3.5 cm. The current paper presents 97 patients with meningiomas with a minimum volume of 10 cm(3), treated with a prescription dose of 12 Gy (or sometimes less to protect neighbouring structures). The post-treatment assessment of these patients, the early response to treatment and the complications of treatment are presented.
There were 97 patients, 70 females and 27 males. The mean age was 48.1 years (range 20.4-87.2 years). The mean follow-up was 54 months (range 25-86 months). All tumours had a volume of 10 cm(3) or more. The mean volume was 15.9 cm(3) (range 10.0-43.2 cm(3)). Post-treatment follow-up used quantitative and qualitative assessments, which are described.
No tumour continued to grow. Twenty-seven were smaller and 72 unchanged in volume. Three patients suffered adverse radiation effects (defined as a new post-treatment oedema detected on the magnetic resonance image with or without contrast leakage). In one case this was silent. In two cases the clinical and radiological effects were temporary and resolved completely.
It is suggested on the basis of this material that the dosimetry used here permits the safe Gamma Knife treatment of larger meningiomas within the range reported. The early radiological response is encouraging, but further follow-up is needed to check long term tumour control. A qualitative method of tumour volume assessment is presented. It seems to be a simpler and more reliable way of assessing tumour volume changes than other methods currently in routine use.
传统上,伽玛刀治疗仅限于直径不超过3 - 3.5厘米的肿瘤。本文介绍了97例最小体积为10立方厘米的脑膜瘤患者,给予12 Gy的处方剂量(有时为保护邻近结构剂量会更低)进行治疗。展示了这些患者的治疗后评估、对治疗的早期反应及治疗并发症。
患者共97例,女性70例,男性27例。平均年龄48.1岁(范围20.4 - 87.2岁)。平均随访时间54个月(范围25 - 86个月)。所有肿瘤体积均为10立方厘米或更大。平均体积为15.9立方厘米(范围10.0 - 43.2立方厘米)。治疗后随访采用了定量和定性评估,具体情况已作描述。
无肿瘤继续生长。27例体积缩小,72例体积不变。3例患者出现放疗不良反应(定义为磁共振成像上检测到新的治疗后水肿,有或无对比剂渗漏)。其中1例无症状。2例的临床和影像学效应为暂时性,且完全消退。
基于该资料表明,此处使用的剂量测定法允许在报告范围内对较大的脑膜瘤进行安全的伽玛刀治疗。早期影像学反应令人鼓舞,但需要进一步随访以检查长期肿瘤控制情况。提出了一种肿瘤体积评估的定性方法。与目前常规使用的其他方法相比,它似乎是一种更简单、更可靠的评估肿瘤体积变化的方法。